NZ506623A - Acylated betulin and dihydrobetulin derivatives, preparation thereof and use in treatment of retroviral infections - Google Patents
Acylated betulin and dihydrobetulin derivatives, preparation thereof and use in treatment of retroviral infectionsInfo
- Publication number
- NZ506623A NZ506623A NZ506623A NZ50662399A NZ506623A NZ 506623 A NZ506623 A NZ 506623A NZ 506623 A NZ506623 A NZ 506623A NZ 50662399 A NZ50662399 A NZ 50662399A NZ 506623 A NZ506623 A NZ 506623A
- Authority
- NZ
- New Zealand
- Prior art keywords
- preparation
- treatment
- optionally substituted
- retroviral infections
- carboxyacyl
- Prior art date
Links
- JZZMDHQYBFQRMW-ROUWMTJPSA-N (1s,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-propan-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol Chemical class C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CC[C@@H](C(C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C JZZMDHQYBFQRMW-ROUWMTJPSA-N 0.000 title 1
- 206010038997 Retroviral infections Diseases 0.000 title 1
- FVWJYYTZTCVBKE-ROUWMTJPSA-N betulin Chemical class C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C FVWJYYTZTCVBKE-ROUWMTJPSA-N 0.000 title 1
- 150000002431 hydrogen Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000002861 (C1-C4) alkanoyl group Chemical group 0.000 abstract 1
- 125000000349 (Z)-3-carboxyprop-2-enoyl group Chemical group O=C([*])/C([H])=C([H])\C(O[H])=O 0.000 abstract 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004031 fumaroyl group Chemical group C(\C=C\C(=O)*)(=O)* 0.000 abstract 1
- -1 glutaryl Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002730 succinyl group Chemical group C(CCC(=O)*)(=O)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7644998P | 1998-03-02 | 1998-03-02 | |
| PCT/US1999/004605 WO1999045025A1 (en) | 1998-03-02 | 1999-03-02 | Acylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ506623A true NZ506623A (en) | 2002-10-25 |
Family
ID=22132095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ506623A NZ506623A (en) | 1998-03-02 | 1999-03-02 | Acylated betulin and dihydrobetulin derivatives, preparation thereof and use in treatment of retroviral infections |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6172110B1 (enExample) |
| EP (1) | EP1068219B1 (enExample) |
| JP (1) | JP2002505337A (enExample) |
| AT (1) | ATE348839T1 (enExample) |
| AU (1) | AU762404B2 (enExample) |
| CA (1) | CA2322868C (enExample) |
| DE (1) | DE69934486T2 (enExample) |
| DK (1) | DK1068219T3 (enExample) |
| ES (1) | ES2281960T3 (enExample) |
| NZ (1) | NZ506623A (enExample) |
| PT (1) | PT1068219E (enExample) |
| WO (1) | WO1999045025A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6232481B1 (en) * | 2000-01-11 | 2001-05-15 | Regents Of The University Of Minnesota | Method for manufacturing betulinic acid |
| US6656970B2 (en) * | 2000-05-11 | 2003-12-02 | Dabur Research Foundation | Method and compositions for solubilization of pentacyclic triterpenes |
| US7365221B2 (en) * | 2002-09-26 | 2008-04-29 | Panacos Pharmaceuticals, Inc. | Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| WO2004028455A2 (en) * | 2002-09-26 | 2004-04-08 | Panacos Pharmaceuticals, Inc. | Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| AU2004210162A1 (en) * | 2003-01-29 | 2004-08-19 | Panacos Pharmaceuticals, Inc. | Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| US7537765B2 (en) * | 2003-01-29 | 2009-05-26 | Panacos Pharmaceuticals, Inc. | Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| US7026305B2 (en) * | 2003-04-14 | 2006-04-11 | Meharry Medical College | Anti-HIV agents with dual sites of action |
| EP1730163A4 (en) * | 2004-03-17 | 2009-12-30 | Panacos Pharmaceuticals Inc | Pharmaceutical salts of 3-O- (3,3-dimethylsuccinyl) betulinic acid |
| US20050215544A1 (en) * | 2004-03-24 | 2005-09-29 | Pin-Fang Lin | Methods of treating HIV infection |
| US7776863B2 (en) * | 2004-03-24 | 2010-08-17 | Bristol-Myers Squibb Company | Methods of treating HIV infection |
| WO2005112929A2 (en) * | 2004-05-20 | 2005-12-01 | Cornell Research Foundation, Inc. | Anti-hiv-1 activity of betulinol derivatives |
| US7282521B2 (en) * | 2004-05-24 | 2007-10-16 | University Of North Carolina At Chapel Hill | Anti-retroviral moronic acid derivatives |
| US8008280B2 (en) * | 2004-09-10 | 2011-08-30 | Biorings Llc | Betulinol derivatives as anti-HIV agents |
| TW200628161A (en) * | 2004-11-12 | 2006-08-16 | Panacos Pharmaceuticals Inc | Novel betulin derivatives, preparation thereof and use thereof |
| BRPI0610668A2 (pt) * | 2005-04-12 | 2010-07-13 | Panacos Pharmaceuticals Inc | polimorfas de di-n-metil-d-glucamina do ácido 3-o-(3',3'-dimetilsuccinil) betulìnico |
| FI121468B (fi) * | 2006-06-07 | 2010-11-30 | Valtion Teknillinen | Betuliiniperäiset yhdisteet antimikrobisina aineina |
| US20080039428A1 (en) * | 2006-06-29 | 2008-02-14 | Panacos Pharmaceuticals, Inc. | Antiretroviral combination therapy |
| WO2008057420A2 (en) | 2006-11-03 | 2008-05-15 | Panacos Pharmaceuticals, Inc. | Extended triterpene derivatives |
| US20110152229A1 (en) * | 2006-11-22 | 2011-06-23 | Duke University | Betulinic acid derivatives as anti-hiv agents |
| US8269026B2 (en) * | 2008-01-03 | 2012-09-18 | Vertex Pharmaceuticals Incorporated | Lupane derivatives useful for treating HIV |
| KR100941595B1 (ko) * | 2008-06-05 | 2010-02-11 | 주식회사 알앤엘바이오 | 바이러스 억제제로서 유용한 트리테르페노이드계 화합물 |
| US20100104669A1 (en) * | 2008-10-28 | 2010-04-29 | Scheffler Armin | Method for preparing an aqueous solution containing triterpenic acid, aqueous solution containing triterpenic acid, and use thereof |
| BR112012030810A2 (pt) * | 2010-06-04 | 2019-09-24 | Bristol-Myers Squibb Company | "c-28 amidas de derivados de ácido c-3 betulínico modificados como inibidores de maturação de hiv" |
| CA2801487C (en) * | 2010-06-04 | 2017-12-05 | Bristol-Myers Squibb Company | Modified c-3 betulinic acid derivatives as hiv maturation inhibitors |
| RU2496785C1 (ru) * | 2012-09-24 | 2013-10-27 | Федеральное государственное бюджетное учреждение науки Институт технической химии Уральского отделения Российской академии наук (ИТХ УрО РАН) | Тритерпеноиды с фрагментом ен-нитрила в а-пентацикле |
| PL227790B1 (pl) | 2015-08-13 | 2018-01-31 | Slaski Univ Medyczny W Katowicach | Fosfoniany acetylenowych pochodnych betuliny o działaniu przeciwnowotworowym, sposób ich wytwarzania i zastosowanie. |
| PL237998B1 (pl) | 2018-05-28 | 2021-06-28 | Narodowy Inst Lekow | Fosfonowe pochodne kwasu 3-karboksyacylobetulinowego, sposób ich otrzymywania oraz ich zastosowanie |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01143832A (ja) * | 1987-12-01 | 1989-06-06 | Toa Nenryo Kogyo Kk | 制癌剤 |
| FR2683531B1 (fr) * | 1991-11-13 | 1993-12-31 | Rhone Poulenc Rorer Sa | Nouveaux derives du lupane, leur preparation et les compositions pharmaceutiques qui les contiennent. |
| US5679828A (en) * | 1995-06-05 | 1997-10-21 | Biotech Research Labs, Inc. | Betulinic acid and dihydrobetulinic acid derivatives and uses therefor |
-
1999
- 1999-03-02 NZ NZ506623A patent/NZ506623A/xx unknown
- 1999-03-02 AT AT99909758T patent/ATE348839T1/de not_active IP Right Cessation
- 1999-03-02 DE DE69934486T patent/DE69934486T2/de not_active Expired - Fee Related
- 1999-03-02 CA CA002322868A patent/CA2322868C/en not_active Expired - Fee Related
- 1999-03-02 JP JP2000534567A patent/JP2002505337A/ja active Pending
- 1999-03-02 PT PT99909758T patent/PT1068219E/pt unknown
- 1999-03-02 DK DK99909758T patent/DK1068219T3/da active
- 1999-03-02 EP EP99909758A patent/EP1068219B1/en not_active Expired - Lifetime
- 1999-03-02 ES ES99909758T patent/ES2281960T3/es not_active Expired - Lifetime
- 1999-03-02 AU AU28894/99A patent/AU762404B2/en not_active Ceased
- 1999-03-02 WO PCT/US1999/004605 patent/WO1999045025A1/en not_active Ceased
- 1999-03-02 US US09/260,078 patent/US6172110B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DK1068219T3 (da) | 2007-04-30 |
| AU2889499A (en) | 1999-09-20 |
| CA2322868C (en) | 2009-02-03 |
| JP2002505337A (ja) | 2002-02-19 |
| CA2322868A1 (en) | 1999-09-10 |
| PT1068219E (pt) | 2007-03-30 |
| EP1068219B1 (en) | 2006-12-20 |
| EP1068219A4 (en) | 2005-05-25 |
| DE69934486T2 (de) | 2007-10-04 |
| WO1999045025A1 (en) | 1999-09-10 |
| ATE348839T1 (de) | 2007-01-15 |
| DE69934486D1 (de) | 2007-02-01 |
| EP1068219A1 (en) | 2001-01-17 |
| ES2281960T3 (es) | 2007-10-01 |
| AU762404B2 (en) | 2003-06-26 |
| US6172110B1 (en) | 2001-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1068219T3 (da) | Acylerede betulin- og dihydrobetulinderivater samt fremstilling og anvendelse deraf | |
| DE69823344D1 (de) | Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen | |
| AU6645998A (en) | Oxygen or sulfur containing heteroaromatics as factor xa inhibitors | |
| AU4064597A (en) | Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof | |
| BR0014651A (pt) | Inibidores de adesão de célula mediada por "alfa" l beta2 | |
| EE9900217A (et) | Sulfiinhappe derivaadid, nende valmistamine ja kasutamine | |
| AU2733997A (en) | N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors | |
| DK0977741T3 (da) | Substituerede phenylderivater, deres fremstilling og anvendelse | |
| DE19675051I2 (de) | Aminosaeurederivate | |
| MXPA04001037A (es) | Derivados de n-fenilpirrol guanidina como ligandos del receptor de melanocortina. | |
| JO2256B1 (en) | Renin inhibitors | |
| AP9701041A0 (en) | Pyridylpyrrole compounds. | |
| BG103947A (en) | Derivatives of 9-oxymerythromycin | |
| NO953372D0 (no) | Anvendelse av lamotrigin ved behandling av neuro-AIDS | |
| NO20065075L (no) | Ikke-nukleosidbaserte revers-transkriptase-inhibitorer. | |
| MXPA04006041A (es) | Antivirales de piridoquinoxalina. | |
| TR200000907T2 (tr) | Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri. | |
| NZ308398A (en) | 2-amino benzoxazin-4-one derivatives and medicaments | |
| PT775118E (pt) | Derivados de benzimidazole com actividade dopaminergica | |
| WO2004028455A3 (en) | Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof | |
| ATE201595T1 (de) | Metallporphyrinzusammensetzungen | |
| DE60005517D1 (de) | Kaliumkanal-blockierende mittel | |
| PT996439E (pt) | Beta-alcoxiacrilatos contra a malaria | |
| NZ504614A (en) | Echinocandin derivatives and application as anti-fungal agents | |
| NO963791L (no) | Peptidderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| ASS | Change of ownership |
Owner name: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HIL, US Free format text: OLD OWNER(S): THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL; V. I. TECHNOLOGIES, INC. Owner name: PANACOS PHARMACEUTICALS, INC., US Free format text: OLD OWNER(S): THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL; V. I. TECHNOLOGIES, INC. Owner name: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HIL, US Free format text: OLD OWNER(S): THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL; PANACOS PHARMACEUTICALS, INC.; THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL; PANACOS PHARMACEUTICALS, INC. Owner name: PANACOS PHARMACEUTICALS, INC., US Free format text: OLD OWNER(S): THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL; PANACOS PHARMACEUTICALS, INC.; THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL; PANACOS PHARMACEUTICALS, INC. |